DiaMedica Therapeutics Inc. (DMAC)

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020	2019	2018	2017	2016
Revenue	0	0	0	0.5	0	0
Gross Profit	0	0	0	0.5	0	0
Selling, General & Admin	4.88	4.49	3.69	2.74	1.31	0.6
Research & Development	8.77	8.21	7.9	4.52	3.21	1.73
Operating Expenses	13.65	12.7	11.59	7.26	4.52	2.33
Operating Income	-13.65	-12.7	-11.59	-6.76	-4.52	-2.33
Other Expense / Income	-0.03	-0.43	-0.98	-1.11	-0.26	-0.11
Pretax Income	-13.61	-12.27	-10.62	-5.65	-4.26	-2.22
Income Tax	0.03	0.03	0.03	0.08	0	0
Net Income	-13.64	-12.3	-10.65	-5.73	-4.26	-2.22
Net Income Common	-13.64	-12.3	-10.65	-5.73	-4.26	-2.22
Shares Outstanding (Basic)	21	16	12	8	6	5
Shares Outstanding (Diluted)	21	16	12	8	6	5
Shares Change	32.48%	30.80%	54.81%	30.45%	25.34%	-
EPS (Basic)	-0.65	-0.78	-0.89	-0.74	-0.72	-0.47
EPS (Diluted)	-0.65	-0.78	-0.89	-0.74	-0.72	-0.47
Free Cash Flow Per Share	-0.59	-0.59	-0.76	-0.74	-0.66	-0.63
Gross Margin	-	-	-	100.00%	-	-
Operating Margin	-	-	-	-1352.20%	-	-
Profit Margin	-	-	-	-1146.80%	-	-
Free Cash Flow Margin	-	-	-	-1149.20%	-	-
Effective Tax Rate	-0.21%	-0.22%	-0.29%	-1.41%	0.00%	0.00%
EBITDA	-13.53	-12.2	-10.55	-5.64	-4.26	-2.22
EBITDA Margin	-	-	-	-1127.80%	-	-
Depreciation & Amortization	0.08	0.07	0.07	0.02	0	0
EBIT	-13.61	-12.27	-10.62	-5.65	-4.26	-2.22
EBIT Margin	-	-	-	-1130.80%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).